Personalised cancer medicine von Jackson, Sarah E., Chester, John D.

Volltext

Unifying Themes in Urothelial Cancers von Chester, John D.

Volltext

Efficient Intravenous Tumor Targeting Using the αvβ6 Integrin-Selective Precision Virotherapy Ad5NULL-A20 von Davies, James A., Marlow, Gareth, Uusi-Kerttula, Hanni K., Seaton, Gillian, Piggott, Luke, Badder, Luned M., Clarkson, Richard W. E., Chester, John D., Parker, Alan L.

Volltext

Immune Recruitment and Therapeutic Synergy: Keys to Optimizing Oncolytic Viral Therapy? von NAIK, Jay D, TWELVES, Christopher J, SELBY, Peter J, VILE, Richard G, CHESTER, John D

Volltext

Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, rand... von Sternberg, Cora N, Dr, Skoneczna, Iwona, MD, Kerst, J Martijn, PhD, Albers, Peter, Prof, Fossa, Sophie D, Prof, Agerbaek, Mads, MD, Dumez, Herlinde, Prof, de Santis, Maria, MD, Théodore, Christine, MD, Leahy, Michael G, Chester, John D, Prof, Verbaeys, Antony, Prof, Daugaard, Gedske, Prof, Wood, Lori, MD, Witjes, J Alfred, PhD, de Wit, Ronald, Prof, Geoffrois, Lionel, MD, Sengelov, Lisa, DMSc, Thalmann, George, Prof, Charpentier, Danielle, MD, Rolland, Frédéric, MD, Mignot, Laurent, MD, Sundar, Santhanam, MRCP, Symonds, Paul, Prof, Graham, John, FRCP, Joly, Florence, Prof, Marreaud, Sandrine, MD, Collette, Laurence, PhD, Sylvester, Richard, ScD

Volltext

Development of a low-seroprevalence, αvβ6 integrin-selective virotherapy based on human adenovirus type 10 von Bates, Emily A., Davies, James A., Váňová, Jana, Nestić, Davor, Meniel, Valerie S., Koushyar, Sarah, Cunliffe, Tabitha G., Mundy, Rosie M., Moses, Elise, Uusi-Kerttula, Hanni K., Baker, Alexander T., Cole, David K., Majhen, Dragomira, Rizkallah, Pierre J., Phesse, Toby, Chester, John D., Parker, Alan L.

Volltext

Ad5NULL-A20: A Tropism-Modified, αvβ6 Integrin-Selective Oncolytic Adenovirus for Epithelial Ovarian Cancer Therapies von Uusi-Kerttula, Hanni, Davies, James A., Thompson, Jill M., Wongthida, Phonphimon, Evgin, Laura, Shim, Kevin G., Bradshaw, Angela, Baker, Alexander T., Rizkallah, Pierre J., Jones, Rachel, Hanna, Louise, Hudson, Emma, Vile, Richard G., Chester, John D., Parker, Alan L.

Volltext

Incorporation of Peptides Targeting EGFR and FGFR1 into the Adenoviral Fiber Knob Domain and Their Evaluation as Targeted Cancer Therapies von Uusi-Kerttula, Hanni, Legut, Mateusz, Davies, James, Jones, Rachel, Hudson, Emma, Hanna, Louise, Stanton, Richard J, Chester, John D, Parker, Alan L

Volltext

Identification of folate receptor α (FRα) binding oligopeptides and their evaluation for targeted virotherapy applications von Hulin-Curtis, Sarah L., Davies, James A., Nestić, Davor, Bates, Emily A., Baker, Alexander T., Cunliffe, Tabitha G., Majhen, Dragomira, Chester, John D., Parker, Alan L.

Volltext

Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle‐invasive transitional cell carcinoma of the bladder von Blick, Christopher, Hall, Peter, Pwint, Thinn, Al‐Terkait, Faisal, Crew, Jeremy, Powles, Thomas, Macaulay, Valentine, Munro, Nicholas, Douglas, David, Kilbey, Neviana, Protheroe, Andrew, Chester, John D.

Volltext

Phase I and Pharmacokinetic Study of Intravenous Irinotecan Plus Oral Ciclosporin in Patients With Fluorouracil-Refractory Metastatic Colon Cancer von CHESTER, John D, JOEL, Simon P, CHEESEMAN, Susan L, HALL, Geoffrey D, BRAUN, Michael S, PERRY, Jackie, DAVIS, Theresa, BUTTON, Christopher J, SEYMOUR, Matthew T

Volltext

Histone deacetylase inhibitor trichostatin A sensitises cisplatin-resistant ovarian cancer cells to oncolytic adenovirus von Hulin-Curtis, Sarah L, Davies, James A, Jones, Rachel, Hudson, Emma, Hanna, Louise, Chester, John D, Parker, Alan L

Volltext

Pseudotyped αvβ6 integrin-targeted adenovirus vectors for ovarian cancer therapies von Uusi-Kerttula, Hanni, Davies, James, Coughlan, Lynda, Hulin-Curtis, Sarah, Jones, Rachel, Hanna, Louise, Chester, John D, Parker, Alan L

Volltext

Systemic chemotherapy for patients with bladder cancer – current controversies and future directions von Chester, John D, Hall, Geoffrey D, Forster, Martin, Protheroe, Andrew S

Volltext

High‐dose chemotherapy with haematopoietic stem‐cell support in patients with poor prognosis, relapsed or refractory germ cell tumours von EL‐HELW, LOAIE M., NAIK, JAY D., CHESTER, JOHN D., JOFFE, JOHNATHAN K., SELBY, PETER J., COLEMAN, ROBERT E.

Volltext

Ad5 NULL -A20: A Tropism-Modified, αvβ6 Integrin-Selective Oncolytic Adenovirus for Epithelial Ovarian Cancer Therapies von Uusi-Kerttula, Hanni, Davies, James A, Thompson, Jill M, Wongthida, Phonphimon, Evgin, Laura, Shim, Kevin G, Bradshaw, Angela, Baker, Alexander T, Rizkallah, Pierre J, Jones, Rachel, Hanna, Louise, Hudson, Emma, Vile, Richard G, Chester, John D, Parker, Alan L

Volltext

The Wales Cancer Research Centre: improving cancer care together von Chester, John D, Bond, Jodie R, Batt, Elisabeth A

Volltext

Efficient Intravenous Tumor Targeting Using the αvβ6 Integrin-Selective Precision Virotherapy Ad5 NULL -A20 von Davies, James A, Marlow, Gareth, Uusi-Kerttula, Hanni K, Seaton, Gillian, Piggott, Luke, Badder, Luned M, Clarkson, Richard W E, Chester, John D, Parker, Alan L

Volltext

TOUCAN: A randomised phase II trial of carboplatin and gemcitabine +/- vandetanib in first line treatment of advanced urothelial cell cancer in patients who are not suitable to rec... von Jones, Robert J., Crabb, Simon J., Chester, John D., Elliott, Tony, Huddart, Robert Anthony, Birtle, Alison J., Evans, Linda, Lester, Jason Francis, Huang, Chao, Casbard, Angela Claire, Madden, Tracie-Ann, Griffiths, Gareth

Volltext

A national platform for molecular diagnostics: Results of the Cancer Research U.K. Stratified Medicine Programme von Shaw, Emily, Butler, Rachel, Gonzalez de Castro, David, Griffiths, Michael, Hanby, Andrew, Hair, Jane, Rae, Frances, Rogan, Jane, Morton, Dion, Brenton, James, Chester, John D., Johnston, Stephen R. D., Walker, Ian, Johnson, Peter W. M.

Volltext